Multiple Myeloma | Topics

FDA Lifts Clinical Hold on Phase 1 MELANI-01 Trial for R/R Multiple Myeloma
November 18, 2020

The FDA lifted the clinical hold on the phase 1 MELANI-01 trial, which is evaluating UCARTCS1 for the treatment of patients with relapsed or refractory multiple myeloma.

Bridging Radiation Therapy Safe, Feasible for Patients with R/R Multiple Myeloma
November 16, 2020

“The most important takeaway here is that bridging radiation doesn’t appear to increase the risk of [cytokine release syndrome; CRS] or neurotoxicity,” said lead study author Shwetha Manjunath, MD.

Study Analyzing Daratumumab to Treat Patients with Multiple Myeloma Induces Positive Topline Results
October 22, 2020

Genmab recently announced positive topline results from part 2 of the Phase 3 CASSIOPEIA study examining daratumumab monotherapy as maintenance therapy to treat patients diagnosed with multiple myeloma.